120 Ces Urol 2022; 26(2): 111–121 PŮVODNÍ PRÁCE 3. Chen X, Li X, Garcia MM, et al. Prognostic Factors in Chinese Patients With Penile Invasive Squamous Cell Carcinoma Journal of Andrology 2012; 33: 1276–1281 DOI: 10 2164/jandrol 112 016378 4. Clark PE, Spiess PE, Agarwal N, et al. Penile Cancer Journal of the National Comprehensive Cancer Network J Natl Compr Canc Netw 2013; 11: 594–615 DOI: 10 6004/jnccn 2013 0075 5. Veeratterapillay R, Teo L, Asterling S, Greene D. Oncologic Outcomes of Penile Cancer Treatment at a UK Supraregional Center Urology 2015; 85: 1097–1103 DOI: 101016/j urology 2014 11 048 6. Solsona E, Iborra I, Rubio J, et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes Journal of Urology 2001; 165: 1506–1509 DOI: 101016/S00225347(05)66337-9 7. Schlenker B, Tilki D, Gratzke C, Seitz M, et al. Intermediate‑differentiated invasive (pT1 G2) penile can‑ cer – oncological outcome and follow‑up Urologic Oncology: Seminars and Original Investigations 2011; 29: 782–787 DOI: 101016/j urolonc 2009 08 022 8. Naumann CM, Alkatout I, Al‑Najar A, et al. Lymph‑node metastases in intermediate‑risk squamous cell carcinoma of the penis BJU International 2008; 102: 1102–1106 DOI: 101111/j 1464-410X 2008 07744 x 9. Hakenberg OW, Compérat EM, Minhas S, et al. EAU Guidelines on Penile Cancer: 2014 Update European Urology 2015; 67: 142–150 DOI: 101016/j eururo 2014 10 017 10. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien‑Dindo Classification of Surgical Complications: Five‑Year Experience Annals of Surgery 2009; 250 11. Cabanas RM. An approach for the treatment of penile carcinoma Cancer 1977; 39: 456–466 DOI: https://doi org/101002/1097-0142(197702)39:2<456:AID‑CNCR2820390214>3 0 CO;2-I 12. Joost AP, Leijte RA, Valdés Olmos RA, Omgo E. Nieweg and Simon Horenblas: Anatomical Mapping of Lymphatic Drainage in Penile Carcinoma with SPECT‑CT: Implications for the Extent of Inguinal Lymph Node Dissection European urology 2008; 54: 885–892 13. Brouwer OR, van den Berg NS, Mathe’ron HM, et al. A Hybrid Radioactive and Fluorescent Tracer for Sentinel Node Biopsy in Penile Carcinoma as a Potential Replacement for Blue Dye European Urology 2014; 65: 600–609 14. Souhrn údajů o přípravku – SPC Senti‑Scint‑kit, Nanocoll‑kit, Nano‑Albumon‑kit. Online: http:// wwwsukl cz/modules/medication/ 15. Sadeghi R, Gholami H, Zakavi SR, et al. Accuracy of Sentinel Lymph Node Biopsy for Inguinal Lymph Node Staging of Penile Squamous Cell Carcinoma: Systematic Review and Meta‑Analysis of the Literature The Journal of urology 2012; 187: 25–31 16. De Vries HM, Lee HJ, Lam W, et al. Clinicopathological predictors of finding additional inguinal lym‑ ph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation BJU International n/a DOI: https://doi org/101111/bju15678 17. Sahdev V, Albersen M, Christodoulidou M, et al. Management of non‑visualization following dyna‑ mic sentinel lymph node biopsy for squamous cell carcinoma of the penis BJU International 2016; 119: 573–578 DOI: 101111/bju13680 18. Hungerhuber E, Schlenker B, Frimberger D, et al. Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes World Journal of Urology 2006; 24: 319–324 DOI: 101007/s00345-006-0073-3 19. Brenot‑Rossi I, Houvenaeghel G, Jacquemier J, et al. Nonvisualization of Axillary Sentinel Node Du‑ ring Lymphoscintigraphy: Is There a Pathologic Significance in Breast Cancer? Journal of Nuclear Medicine 2003; 44: 1232–1237 20. Hirche C, Engel H, Hirche Z, et al. Real‑Time Lymphography by Indocyanine Green Fluorescence: Im‑ proved Navigation for Regional Lymph Node Staging Annals of Plastic Surgery Publish Ahead of Print, 9000
RkJQdWJsaXNoZXIy NDA4Mjc=